Prognostic impact of measurable residual clonal hematopoiesis in acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation.

Authors	Lara Bischof, Jule Ussmann, Juliane Grimm, Marius Bill, Dominic Brauer, Donata Backhaus, Lisa Herrmann, Maximilian Merz, Marco Herling, Klaus H Metzeler, Georg-Nikolaus Franke, Vladan Vucinic, Uwe Platzbecker, Sebastian Schwind, Madlen Jentzsch
Journal	Leukemia (Leukemia) Vol. 38 Issue 1 Pg. 198-201 (01 2024) ISSN: 1476-5551 [Electronic] England
PMID	37880479 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Topics	Humans Prognosis Clonal Hematopoiesis Hematopoietic Stem Cell Transplantation Leukemia, Myeloid, Acute (genetics, therapy) Neoplasm, Residual Transplantation Conditioning Recurrence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!